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Editorial
The walk of life: Remote monitoring provides insights into physical
activity during a pandemic
The COVID-19 pandemic has had a major impact on the health,
wellbeing and economic situation of numerous countries. While
some effects can be directly related to the virus, others are the indi-
rect consequence of the measures taken in an attempt to control
the pandemic. For example, the impact of the lockdowns and
related policies that have been instituted in many countries to
reduce transmission of the virus on education, wellbeing, and
economies have been extensively discussed in scientific and popu-
lar media [1]. The potential cardiovascular consequences of a
COVID-19 infection have similarly received significant attention.
For example, cardiac injury (as defined by elevated cardiac tro-
ponin assays) is common in patients hospitalized with COVID-19
infection, occurring in 13%-41% of patients [2,3]. Moreover, struc-
tural abnormalities on cardiac magnetic resonance imaging are
common after COVID-19 infection, but causal relationships of these
tissue changes with the initial infection and future cardiac events
are largely unknown [3]. Acute COVID-19 infection may increase
the susceptibility to AF, as well as promote the evolution of a pro-
thrombotic state [4]. Potential proarrhythmic effects of drugs such
as hydroxychloroquine and azithromycin, which were proposed to
treat patients with a COVID-19 infection, have also been the topic
of intense debate [5,6].
Besides the virus itself and the medication used to treat COVID-
19 infections, the measurements taken in an attempt to control the
pandemic, together with increased anxiety, have also had an
impact on cardiovascular morbidity and mortality. In particular,
there has been a pronounced reduction in hospital admissions for
a variety of cardiovascular conditions during the first wave of the
pandemic, with a substantial deficit in cumulative numbers over
a period of several months [7]. However, less is known about
how lockdown-induced changes in lifestyle may affect individuals
with cardiovascular diseases.
Previous work has suggested a pronounced reduction in self-
reported physical activity during the COVID-19 pandemic [8]. In
the current issue of the International Journal of Cardiology Heart &
Vasculature, Bertagnin et al. [9] investigated the effect of COVID-
19-related lockdown on objective measures of physical activity,
heart rate and thoracic impedance in 211 heart failure patients
with cardiac implantable electronic device (CIED)-based active
home monitoring. The authors identified a 25.9% relative reduction
in physical activity during the lockdown period compared with the
control period (active time per day 8.0% vs. 10.8%; p < 0.001). A
small 2.2% decrease was also noted for mean heart rate while tho-
racic impedance exhibited a slight but significant incease (82.2 vs.
82.7 O; p = 0.001). In addition, patients were interviewed to obtain
patient-reported information on physical activity, anxiety, depres-
sion and medication use. Interestingly, patients’ perceptions about
physical activity showed a very low correlation with remote CIED-
assessed physical activity levels, highlighting the importance of
objective measures enabled by modern telemonitoring equipment,
mobile health applications and wearables.
In some ways, the COVID-19 pandemic provides an interesting
natural experiment to assess the impact of certain lifestyle factors
on cardiovascular characteristics. Conceptually, the link between
physical activity and cardiovascular disease is well established.
Physical inactivity is a key modifiable risk factor for heart failure
exacerbation and arrhythmias [10,11]. Conversely, (intense) exer-
cise is an important trigger for arrhythmias in patients with cate-
cholaminergic polymorphic ventricular tachycardia and certain
forms of long-QT syndrome and arrhythmogenic cardiomyopathy,
as well as being a risk factor for atrial fibrillation [12,13]. However,
how more modest changes in day-to-day physical activity may
affect arrhythmogenic risk is incompletely understood. While the
current study, including 211 patients with home monitoring, is
likely underpowered to detect differences in the incidence of
arrhythmias, especially given the skewed nature of the data, it is
interesting to note that the number of episodes of ventricular
tachycardia, ventricular fibrillation, and the occurrence of anti-
tachycardia pacing are numerically considerably lower during the
lockdown period in the study by Bertagnin et al. [9]. In agreement,
O’Shea et al. [14] recently reported in 5963 ICD patients a signifi-
cant 32% reduction in ventricular arrhythmias needing device ther-
apies coinciding with measures of social isolation, although
changes in physical activity were not reported in this study.
Of course, the lockdown and the COVID-19-related circum-
stances that necessitated these lockdowns may also induce numer-
ous other changes that can affect cardiovascular health and/or
arrhythmogenesis, including increased anxiety, dietary changes,
as well as reductions in air pollution due to the reductions in traffic
and closure of shops and factories [15]. Unfortunately, in contrast
to physical activity, these factors are hard to measure objectively
in an individual patient. Moreover, the cardiovascular effects of
these factors may exhibit complex interactions and may depend
on the duration of the COVID-19-related circumstances. For exam-
ple, a reduction in physical activity might initially reduce the
occurrence of arrhythmogenic triggers, but in the long term, the
negative impact of physical inactivity on heart failure and general
cardiovascular health may increase arrhythmogenic risk again.
https://doi.org/10.1016/j.ijcha.2021.100772
2352-9067/ 2021 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
IJC Heart & Vasculature 33 (2021) 100772
Contents lists available at ScienceDirect
IJC Heart & Vasculature
journal homepage: www.journals .e lsevier .com/i jc -heart -and-vasculature
Downloaded for Anonymous User (n/a) at Radboud University from ClinicalKey.com by Elsevier on October 08, 
2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
Together, these data indicate that COVID-19 has had a tremen-
dous direct and indirect impact on cardiovascular health. The
COVID-19-related lockdown and fear of infection have drastically
reduced physical activity, which in the short term appears to coin-
cide with a reduced incidence of cardiac arrhythmias in heart fail-
ure patients. Advances in telemonitoring using data from CIEDs,
mobile health applications or wearables are providing unique
opportunities to objectively and longitudinally quantify the tem-
poral relationship between risk factors, lifestyle components and
cardiovascular outcomes. The growing possibilities for remote
monitoring of rhythm and risk factors were used widely for remote
assessment and manage of patients through teleconsultation dur-
ing the COVID-19 pandemic [16,17] and will benefit patients long
beyond the lockdown restrictions.
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